1998
Vitamin A Supplementation and Human Immunodeficiency Virus Load in Injection Drug Users
Semba R, Lyles C, Margolick J, Caiaffa W, Farzadegan H, Cohn S, Vlahov D. Vitamin A Supplementation and Human Immunodeficiency Virus Load in Injection Drug Users. The Journal Of Infectious Diseases 1998, 177: 611-616. PMID: 9498439, DOI: 10.1086/514235.Peer-Reviewed Original ResearchConceptsCD4 lymphocyte countHigh-dose vitaminHIV loadInjection drug usersLymphocyte countDrug usersVitamin AHuman immunodeficiency virus (HIV) infectionPlacebo-controlled clinical trialHuman immunodeficiency virus loadImmunodeficiency virus infectionUse of vitaminsPlasma vitaminHIV replicationVirus loadClinical trialsVirus infectionClinical investigationRetinol equivalentsSupplementationRetinoic acid response elementVitaminWeeksAcid response elementCount
1995
Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial
Harrison K, Vlahov D, Jones K, Charron K, Clements M. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 386-390. PMID: 7552502, DOI: 10.1097/00042560-199511000-00012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesClinical Trials as TopicComprehensionConsent FormsDouble-Blind MethodEducational StatusEligibility DeterminationFemaleHIV InfectionsHumansInformed ConsentMaleMiddle AgedPatient SelectionResearch DesignResearch SubjectsSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsInjection drug usersHIV vaccine trialsVaccine trialsDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPhase II trialInformed consent procedureConsent proceduresII trialVirus infectionHigh riskMedical reasonsMedical eligibilityTrialsConsent processEnrollmentFollowInfectionFalse testVisits